BLEOMYCIN

Search structure
Synonyms:
Status: Approved (1973)
Entry Type: Small molecule
Molecule Category: Parent
ATC: L01DC01
UNII: 40S1VHN69B

Structure
InChI Key OYVAGSVQBOHSSS-UAPAGMARSA-O
Smile Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1
InChI
InChI=1S/C55H83N17O21S3/c1-20-33(69-46(72-44(20)58)25(12-31(57)76)64-13-24(56)45(59)82)50(86)71-35(41(26-14-61-19-65-26)91-54-43(39(80)37(78)29(15-73)90-54)92-53-40(81)42(93-55(60)88)38(79)30(16-74)89-53)51(87)66-22(3)36(77)21(2)47(83)70-34(23(4)75)49(85)63-10-8-32-67-28(18-94-32)52-68-27(17-95-52)48(84)62-9-7-11-96(5)6/h14,17-19,21-25,29-30,34-43,53-54,64,73-75,77-81H,7-13,15-16,56H2,1-6H3,(H13-,57,58,59,60,61,62,63,65,66,69,70,71,72,76,82,83,84,85,86,87,88)/p+1/t21-,22+,23+,24-,25-,29-,30+,34-,35-,36-,37+,38+,39-,40-,41-,42-,43-,53+,54-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C55H84N17O21S3+
Molecular Weight 1415.58
AlogP None
Hydrogen Bond Acceptor None
Hydrogen Bond Donor None
Number of Rotational Bond None
Polar Surface Area None
Molecular species None
Aromatic Rings None
Heavy Atoms None

Pharmacology

Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Hydrolase
- - - - 10.15
Enzyme Oxidoreductase
- 1470-3810 - - 97.5

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Neoplasms 4 D009369 ClinicalTrials
Seminoma 3 D018239 ClinicalTrials
HIV Infections 3 D015658 ClinicalTrials
Hodgkin Disease 3 D006689 ClinicalTrials
Sex Cord-Gonadal Stromal Tumors 3 D018312 ClinicalTrials
Testicular Neoplasms 3 D013736 ClinicalTrials
Lymphoma, Large B-Cell, Diffuse 3 D016403 ClinicalTrials
Lymphoma 3 D008223 ClinicalTrials
Pericardial Effusion 3 D010490 ClinicalTrials
Ovarian Neoplasms 3 D010051 ClinicalTrials
Hodgkin Disease 3 D006689 ClinicalTrials
Head and Neck Neoplasms 2 D006258 ClinicalTrials
Rectal Neoplasms 2 D012004 ClinicalTrials
Lymphedema 2 D008209 ClinicalTrials
Central Nervous System Neoplasms 2 D016543 ClinicalTrials
Vulvar Neoplasms 2 D014846 ClinicalTrials
Lymphoma, T-Cell, Peripheral 2 D016411 ClinicalTrials
Carcinoma, Squamous Cell 2 D002294 ClinicalTrials
Neoplasms, Germ Cell and Embryonal 2 D009373 ClinicalTrials
Stomach Neoplasms 1 D013274 ClinicalTrials
Liver Neoplasms 1 D008113 ClinicalTrials

Related Entries

Scaffolds

Salt

Cross References

Resources Reference
CAS NUMBER 11056-06-7
ChEBI 3139
ChEMBL CHEMBL403664
EPA CompTox DTXSID20872327
FDA SRS 40S1VHN69B
KEGG C06854
PubChem 5460769
SureChEMBL SCHEMBL134155
CONTENTS